(Q36638150)

English

Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present

scientific article published on February 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

0 references

1 reference

Europe PubMed Central

Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

John E Hokanson

4

object named as

John E Hokanson

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

author name string

David L McClure

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Robert J Valuck

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Morton Glanz

3

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Pharmacoepidemiology and Drug Safety

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

132-143

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Beneficial effects of pravastatin on fasting hyperinsulinemia in elderly hypertensive hypercholesterolemic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Short-term safety and efficacy of low-dose simvastatin in elderly patients with hypertensive hypercholesterolemia and fasting hyperinsulinemia.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Lovastatin does not affect oral glucose tolerance in hypercholesterolemic patients.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Simvastatin in severe hypercholesterolaemia: a placebo controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Systematic Reviews in Health Care

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1341

21 January 2018

Identifiers

10.1002/PDS.1341

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36638150&oldid=1644888171"